The Impact of GLP-1 Drugs on Nash Treatment Market

Discussion on the significant impact of GLP-1 drugs in the market, particularly in the treatment of fatty liver disease and early stages of Nash. It also explores concerns about the dominance of GLP-1 drugs and their limited impact on fibrosis, leading to market reactions and speculation about the effects on various businesses.